@article{ledu:hal-01321413, TITLE = {{Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?}}, AUTHOR = {Le Du, Fanny and Eckhardt, Bedrich L. and Lim, Bora and Litton, Jennifer K. and Moulder, Stacy and Meric-Bernstam, Funda and Gonzalez-Angulo, Ana M. and Ueno, Naoto T}, URL = {https://univ-rennes.hal.science/hal-01321413}, JOURNAL = {{Oncotarget}}, PUBLISHER = {{Impact journals}}, VOLUME = {6}, NUMBER = {15}, PAGES = {12890--12908}, YEAR = {2015}, MONTH = May, DOI = {10.18632/oncotarget.3849}, KEYWORDS = {Epithelial-Mesenchymal Transition ; Female ; Gene Expression Profiling ; Humans ; Immunotherapy ; Molecular Targeted Therapy ; Precision Medicine ; Targeted therapy ; triple-negative breast cancer ; Triple Negative Breast Neoplasms}, HAL_ID = {hal-01321413}, HAL_VERSION = {v1}, }